GSK Plc
NYSE: GSK
$36.20
+$0.30 (+0.8%)
Real Time Data Delayed 15 Min.
GSK Articles
Idearc (NYSE: IAR) Big earnings miss mugs shares, Down to $11.21 from 52-week high of $38. Infineon Technologies (NYSE: IFX) German company posts weak numbers. Sells off to $7.89 from 52-week high of...
Published:
Alliance Data Systems (ADS) was informed by Blackstone that conditions likely won’t be satisfied to complete the merger; stock trading down close to 40%.American Express (AXP) reports earnings...
Published:
Markets in Europe were up modestly at 7.10 AM The FTSE rose .6% to 6,322. GlaxoSmithKline (GSK) was up 1% to 1288. Northern Rock was down 2.2% to 88.7. Vodafone (VOD) was up 1.5% to 184.5. The DAXX...
Published:
Now that the FDA has forced GlaxoSmithKline (GSK) to put a "black label" on its diabetes drug Avandia, the competition is going for a coup de grace. Takeda Pharmaceutical Co Ltd said on Thursday it...
Published:
According to Reuters, Barclays (BCS) took a $2.7 billion write-down due to exposure to subprime markets. Reuters writes that IBM (IBM) will push into the business of running huge data centers for...
Published:
GlaxoSmithKline’s (GSK) diabetes drug Avandia has such frightening side effects that the FDA will probably make it carry a "black box" label. Studies have found that the treatment can increase risk...
Published:
GlaxoSmithKline’s (NYSE:GSK) Avandia sales might not just weak after the reports of cardiovascular risks were reported. If this research is accurate, the sales might be on the path to...
Published:
Last Updated:
According to Reuters, shares in Amazon (AMZN) dropped on concerns about margins in it latest earnings. Reuters writes that RIM (RIMM) will start to market its Blackberry in China. Reuters reports...
Published:
Two more studies show that GlaxoSmithKline (GSK) blockbuster diabetes drug Avandia has significant health risks. According to The Wall Street Journal "the Food and Drug Administration is considering...
Published:
Markets in Europe were higher at 6.05 AM New York time. The FTSE rose 1.1% to 6,264. Barclays (BCS) rose 1.5% to 642.5. GlaxoSmithKline (GSK) rose 1.4% to 1305. The DAXX rose 1.1% to 7,582. Daimler...
Published:
Markets in Europe were higher at 5,40 AM New York time. The FTSE rose 1% to 6,126. BHP Billiton (BHP) was up 4.4% to 1278. GlaxoSmithKline (GSK) was up 1% to 1284. The DAXX rose .6% to 7,422....
Published:
Markets in Europe were off modestly at 5.50 AM New York time. The FTSE fell .2% to 6,211. Barclays (BCS) was up 2.4% to 594.5. BHP Billiton (BHP) was off 1.4 to 1355. GSK (GSK) was up 1% to 1279. The...
Published:
Pozen (POZN) got the bad news that the FDA has "delayed approval of an experimental two-in-one migraine drug from GlaxoSmithKline (GSK)", according to Reuters. The drug, Trexima combines Glaxo’s...
Published:
The U.S. Centers for Medicare & Medicaid Services issued its final ruling governing use of a class of anemia drugs including Amgen’s (AMGN) Aranesp .The CMOS guided doctors to restrict the use...
Published:
Markets in Europe were higher at 6.50 AM New York time. The FTSE rose .7% to 6,295. BP (BP) was down 1.4% to 565.5. BT (BT) was up 1.9% to 315.75. GSK (GSK) was up 1.4% to 1273. The DAXX rose 1.1% to...
Published: